Anesthetic drugs & techniques

Comparison of the effects of sugammadex versus neostigmine for reversal of neuromuscular block on hospital costs of care

Br J AnaesthPublished Retrospective cohort study

Main finding · Direct costs (registry data)Result — go to the resultDifference −1.3 % 95% CI −0.5 to −2.2%

Authors' conclusion

The effects of using sugammadex on costs of care depend on patient risk, defined based on comorbidities and admission status. We observed lower costs of care in patients with lower risk and higher costs of care in hospitalised surgical patients with severe comorbidities.

Study context

Population
Adult surgical patients receiving NMBAs and reversal, two academic healthcare networks, 2016–2021
Participants
79,474 patients
Exposure
Sugammadex vs neostigmine for reversal of NMB
Outcome
Hospital costs of care (direct costs; total costs in US dollars)
Methodological detailstwo academic healthcare networks, registry data, Healthcare Cost and Utilization Project-National Inpatient Sample (HCUP-NIS) matched cohort
  • Two academic healthcare networks
  • Registry data
  • HCUP-NIS matched cohort

Main finding

Direct costs (registry data)

Difference

−1.3 %

95% CI −0.5 to −2.2%

P = 0.002

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeDifference (US$) (95% CI)P value
Total costs, higher-risk patients (ASA ≥3 and preoperative hospitalisation) (subgroup)Higher total costs620 (US$377 to US$865)P < 0.001
OutcomeDifference (US$) (95% CI)P value
Total costs (HCUP-NIS matched cohort)Lower total costs · matched cohort232 (-US$376 to -US$88)P = 0.002
Total costs, lower-risk patients (subgroup)Lower total costs1042 (-US$1198 to -US$884)P < 0.001

Original publication

Comparison of the effects of sugammadex versus neostigmine for reversal of neuromuscular block on hospital costs of care. Br J Anaesth. Published 21 December 2022. doi:10.1016/j.bja.2022.10.015

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.